These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 5788999)

  • 21. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 22. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 24. [Official inspections of a pharmaceutical plant during the registration of new products].
    De Martiis F; Fontani F; Zanotti-Gerosa A
    Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440
    [No Abstract]   [Full Text] [Related]  

  • 25. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacteriological purity--a consideration in the manufacture and packaging of pharmaceuticals.
    Brennan EC; Baker DE; Gasdia SD
    Am J Hosp Pharm; 1968 Jun; 25(6):302-4. PubMed ID: 4968569
    [No Abstract]   [Full Text] [Related]  

  • 27. Use caution when donating drugs, guidelines suggest.
    Riggs B
    CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855
    [No Abstract]   [Full Text] [Related]  

  • 28. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 29. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 30. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 32. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 34. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 35. Aseptic process monitoring--a better strategy. Validation Group, Inc.
    Wilson JD
    PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiopharmaceutical production--radiation safety.
    Fredrickson RL; Myers CB
    IMS Ind Med Surg; 1969 Jul; 38(7):199-204. PubMed ID: 5256328
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbial content in non-sterile pharmaceuticals. I. Introduction.
    Dan Tidsskr Farm; 1968; 42(1):1-4. PubMed ID: 4968767
    [No Abstract]   [Full Text] [Related]  

  • 39. [Regulations for industrial establishments devoted to the manufacture of raw materials for compounding drugs and for laboratories or factories].
    Salud Publica Mex; 1982; 24(2):212-9. PubMed ID: 7112260
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug identification. The problem in dental out-patients.
    Stephen KW; Laird WR
    Br Dent J; 1968 Jun; 124(11):521-5. PubMed ID: 5239909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.